Emergency room physicians still hand out hundreds of thousands of codeine prescriptions for children every year, despite warnings that kids' responses to codeine vary wildly.More >>
Emergency room physicians still hand out hundreds of thousands of codeine prescriptions for children every year, despite warnings that kids' responses to codeine vary wildly. More >>
Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
Triptans consist of a class of drugs called selective 5-hydroxytryptamine subtype 1 (5-HT1) receptor agonists. Migraine headaches are an established and growing market for patient-friendly drug delivery. Triptans constrict blood vessels in the brain and relieve swelling, a mechanism that is thought to provide palliative relief to migraine patients, but also have other properties that may help treat migraine symptoms.
Worldwide, the highest prevalence of migraine occurs in North America. It is approximately 25 percent less frequent in Europe and Central and South America and approximately 67 percent less frequent in Asia and Africa. Most patients with migraine begin having the headaches in childhood, adolescence or early adulthood.
The market and growth prospects for migraine therapeutics are substantial and have attracted an expanding list of players.
Analyzes and evaluates triptan drug classes and products and development-stage candidates and assesses risks and market potential
Provides assessments of indications and markets for triptans and examines key market and commercialization factors
Evaluates the impact of economic, technology, and regulatory factors on triptan drug commercialization
Provides market data and forecasts to 2018
Profiles market sector participants, their product development activities and business strategies
Key Topics Covered:
The Market Opportunity
Market Dynamics Indications and Prescribing Demand Drivers Competitive Landscape Risks and Opportunities